title: Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis.
authors.forename: Stefan W
authors.initials: SW
authors.lastname: Schneider
authors.forename: Sonja
authors.initials: S
authors.lastname: Staender
authors.forename: Bernhard
authors.initials: B
authors.lastname: Schlüter
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Luger
authors.forename: Gisela
authors.initials: G
authors.lastname: Bonsmann
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001706:Biopsy; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged; D012867:Skin / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab